Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10


Update in Critical Care and Acute Respiratory Distress Syndrome 2018.

Douglas IS, Bednash JS, Fein DG, Mallampalli RK, Mansoori JN, Gershengorn HB.

Am J Respir Crit Care Med. 2019 Jun 1;199(11):1335-1343. doi: 10.1164/rccm.201903-0550UP. No abstract available.


The SCFFBXO3 ubiquitin E3 ligase regulates inflammation in atherosclerosis.

Chandra D, Londino J, Alexander S, Bednash JS, Zhang Y, Friedlander RM, Daskivich G, Carlisle DL, Lariviere WR, Nakassa ACI, Ross M, St Croix C, Nyunoya T, Sciurba F, Chen B, Mallampalli RK.

J Mol Cell Cardiol. 2019 Jan;126:50-59. doi: 10.1016/j.yjmcc.2018.11.006. Epub 2018 Nov 16.


Targeting Deubiquitinases in Cancer.

Bednash JS, Mallampalli RK.

Methods Mol Biol. 2018;1731:295-305. doi: 10.1007/978-1-4939-7595-2_25.


Azithromycin decreases NALP3 mRNA stability in monocytes to limit inflammasome-dependent inflammation.

Lendermon EA, Coon TA, Bednash JS, Weathington NM, McDyer JF, Mallampalli RK.

Respir Res. 2017 Jun 28;18(1):131. doi: 10.1186/s12931-017-0608-8.


Targeting the deubiquitinase STAMBP inhibits NALP7 inflammasome activity.

Bednash JS, Weathington N, Londino J, Rojas M, Gulick DL, Fort R, Han S, McKelvey AC, Chen BB, Mallampalli RK.

Nat Commun. 2017 May 11;8:15203. doi: 10.1038/ncomms15203.


RING finger E3 ligase PPP1R11 regulates TLR2 signaling and innate immunity.

McKelvey AC, Lear TB, Dunn SR, Evankovich J, Londino JD, Bednash JS, Zhang Y, McVerry BJ, Liu Y, Chen BB.

Elife. 2016 Nov 2;5. pii: e18496. doi: 10.7554/eLife.18496.


Regulation of inflammasomes by ubiquitination.

Bednash JS, Mallampalli RK.

Cell Mol Immunol. 2016 Nov;13(6):722-728. doi: 10.1038/cmi.2016.15. Epub 2016 Apr 11. Review.


Lyn kinase mediates cell motility and tumor growth in EGFRvIII-expressing head and neck cancer.

Wheeler SE, Morariu EM, Bednash JS, Otte CG, Seethala RR, Chiosea SI, Grandis JR.

Clin Cancer Res. 2012 May 15;18(10):2850-60. doi: 10.1158/1078-0432.CCR-11-2486. Epub 2012 Apr 6.


Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma.

Leeman-Neill RJ, Seethala RR, Singh SV, Freilino ML, Bednash JS, Thomas SM, Panahandeh MC, Gooding WE, Joyce SC, Lingen MW, Neill DB, Grandis JR.

Cancer Prev Res (Phila). 2011 Feb;4(2):230-7. doi: 10.1158/1940-6207.CAPR-10-0249. Epub 2010 Dec 16.

Supplemental Content

Loading ...
Support Center